JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB280114

Mouse PRKAA1 knockout RAW 264.7 cell lysate

Be the first to review this product! 리뷰 제출

|

(0 출판물)

PRKAA1 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included.
3 이미지
Western blot - Mouse PRKAA1 knockout RAW 264.7 cell lysate (AB280114)
  • WB

Lab

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell lysate (AB280114)

Lane 1 : Wild-type RAW 264.7 cell lysate 20μg.

Lane 2 : PRKAA1 knockout RAW 264.7 cell lysate 20 μg.

Lane 3 : Mouse Liver cell lysate 20 μg.

Lane 4 : Neuro2A cell lysate 20 μg.

False colour image of Western blot : Anti-AMPK alpha 1 antibody [2B7] staining at 1/500 dilution, shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution shown in red. In Western blot ab110036 was shown to bind specifically to AMPK alpha 1. A band was observed at 64 kDa in wild-type RAW 264.7 cell lysates with no signal observed at this size in PRKAA1 knockout cell line ab280055 (knockout cell lysate ab280114). To generate this image wild-type and PRKAA1 knockout RAW 264.7 cell lysates were analysed. First samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.

All lanes:

Western blot - Anti-AMPK alpha 1 antibody [2B7] (<a href='/ko/products/primary-antibodies/ampk-alpha-1-antibody-2b7-ab110036'>ab110036</a>) at 1/500 dilution

Lane 1:

Wild-type RAW 264.7 cell lysate at 20 µg

Lane 2:

PRKAA1 knockout RAW 264.7 cell lysate at 20 µg

Lane 2:

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell line (<a href='/ko/products/cell-lines/mouse-prkaa1-knockout-raw-2647-cell-line-ab280055'>ab280055</a>)

Lane 3:

Mouse Liver cell lysate at 20 µg

Lane 4:

Neuro2A cell lysate at 20 µg

Predicted band size: 64 kDa

Observed band size: 64 kDa

false

Sanger Sequencing - Mouse PRKAA1 knockout RAW 264.7 cell lysate (AB280114)
  • Sanger seq

Supplier Data

Sanger Sequencing - Mouse PRKAA1 knockout RAW 264.7 cell lysate (AB280114)

Mouse Prkaa1 KO in Raw264.7 Cells with 2 bp deletion in Exon 4

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell lysate (AB280114)
  • WB

Lab

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell lysate (AB280114)

Lane 1 : Wild-type RAW 264.7 cell lysate 20 μg

Lane 2 : PRKAA1 knockout RAW 264.7 cell lysate 20 μg

Lane 3 : Mouse Liver cell lysate 20 μg

Lane 4 : Neuro2A cell lysate 20 μg

False colour image of Western blot : Anti-AMPK alpha 1 antibody [Y365] staining at 1/1000 dilution shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution shown in red. In Western blot ab32047 was shown to bind specifically to AMPK alpha 1. A band was observed at 64 kDa in wild-type RAW 264.7 cell lysates with no signal observed at this size in PRKAA1 knockout cell line ab280055 (knockout cell lysate ab280114). To generate this image wild-type and PRKAA1 knockout RAW 264.7 cell lysates were analysed. First samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T incubated with secondary antibodies for 1 h at room temperature washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-AMPK alpha 1 antibody [Y365] (<a href='/ko/products/primary-antibodies/ampk-alpha-1-antibody-y365-ab32047'>ab32047</a>) at 1/1000 dilution

Lane 1:

Wild-type RAW 264.7 cell lysate at 20 µg

Lane 2:

Western blot - Mouse PRKAA1 knockout RAW 264.7 cell lysate (ab280114) at 20 µg

Lane 3:

Mouse Liver cell lysate at 20 µg

Lane 4:

Neuro2A cell lysate at 20 µg

Predicted band size: 64 kDa

Observed band size: 64 kDa

false

주요 정보

세포 유형

RAW 264.7

Species or organism

Mouse

조직

Lymphatic

Knockout 검증

Sanger Sequencing,Western blot

질병

Carcinoma

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

제품 세부 정보

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab280114-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Mouse wild-type RAW 264.7 cell lysate", "number":"AB280114-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human PRKAA1 knockout RAW 264.7 cell lysate", "number":"AB280114-CMP01", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
PRKAA1
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing, Western blot
배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

PRKAA1 also known as the alpha 1 catalytic subunit of AMP-activated protein kinase (AMPK) plays an important role in cellular energy homeostasis. It has a molecular mass of approximately 63 kDa. The protein is widely expressed in various tissues including the liver skeletal muscle and brain. As a serine/threonine kinase PRKAA1 reacts to changes in cellular energy status by activating pathways that restore energy balance.
Biological function summary

PRKAA1 acts as an energy sensor and regulator in cells. As part of the AMPK heterotrimeric complex it regulates energy metabolism by phosphorylating various substrates involved in lipid glucose and protein metabolism. PRKAA1 activation results in increased glucose uptake fatty acid oxidation and mitochondrial biogenesis while inhibiting the synthesis of fatty acids cholesterol and triglycerides. This protein plays a significant role in maintaining cellular energy homeostasis and adapting to metabolic stress.

Pathways

PRKAA1 links to both the mTOR signaling pathway and the insulin signaling pathway. In the mTOR pathway it interacts with proteins such as TSC2 and Raptor leading to the inhibition of mTORC1 activity. In the insulin signaling pathway PRKAA1 affects the phosphorylation state of proteins involved in glucose homeostasis. PRKAA1’s regulation of these pathways highlights its importance in metabolic processes and energy balance.

PRKAA1 shows association with metabolic disorders like type 2 diabetes and obesity. In type 2 diabetes dysregulation of PRKAA1-related pathways impacts insulin sensitivity and glucose uptake contributing to disease progression. Furthermore PRKAA1 relates to cardiac diseases often involving proteins such as PGC-1α which is important for mitochondrial biogenesis and energy metabolism in heart tissues. Understanding PRKAA1’s role offers insights into potential therapeutic targets for these metabolic diseases.

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Male

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com